The TNFRSF9 gene (tumor necrosis factor receptor superfamily member 9), related to immune microenvironment, demonstrated a powerful influence on survival outcomes of DLBCL [19]. The gene discussed is TNFRSF9; the disease is diffuse large B-cell lymphoma.